Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / CL A
-
Number of holders
-
156
-
Total 13F shares, excl. options
-
17,639,008
-
Shares change
-
+1,519,687
-
Total reported value, excl. options
-
$1,663,338,785
-
Value change
-
+$145,080,716
-
Put/Call ratio
-
228%
-
Number of buys
-
83
-
Number of sells
-
-68
-
Price
-
$94.35
Significant Holders of REATA PHARMACEUTICALS INC - CL A (RETA) as of Q2 2019
193 filings reported holding RETA - REATA PHARMACEUTICALS INC - CL A as of Q2 2019.
REATA PHARMACEUTICALS INC - CL A (RETA) has 156 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17,639,008 shares
.
Largest 10 shareholders include CPMG Inc (3,023,349 shares), BlackRock Inc. (1,915,707 shares), VANGUARD GROUP INC (1,749,451 shares), FRANKLIN RESOURCES INC (1,158,730 shares), Cormorant Asset Management, LP (806,150 shares), FARALLON CAPITAL MANAGEMENT LLC (800,000 shares), PRICE T ROWE ASSOCIATES INC /MD/ (650,391 shares), WELLINGTON MANAGEMENT GROUP LLP (504,579 shares), STATE STREET CORP (458,040 shares), and MILLENNIUM MANAGEMENT LLC (422,861 shares).
This table shows the top 156 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.